Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bayer AG Updates FY 2013 Revenue Guidance In Line With Analysts' Estimates; Issues FY 2013 Earnings Guidance In Line With Analysts' Estimates-Conference Call


Wednesday, 31 Jul 2013 08:00am EDT 

Bayer AG announced that for fiscal 2013, it expects sales to increase by 4% to 5%, after adjusting for currency and portfolio effects. Based on average exchange rates for the first half of 2013, the Company expect to achieve Group sales of EUR40 billion to EUR41 billion. The Company expect to increase EBITDA, before special items, by a mid single-digit percentage. The Company expect to improve core earnings per share (EPS) by a high single-digit percentage. The Company reported EBITDA of EUR8.029 billion and EPS of EUR5.19 for fiscal 2012. According to I/B/E/S Estimates, analysts on average are expecting the Company to report revenue of EUR40 billion, EBITDA of EUR8.352 million and EPS of EUR5.61 for fiscal 2013. 

Company Quote

131.676
-3.984 -2.94%
31 Jul 2014